PROVIDER PROFILE · NPI 1568435261

Ripple MarfatiaM.D.

PRACTICEMARFATIA MEDICAL PLLCSee all providers at this practice →

Internal MedicineCastile, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

118

Unique beneficiaries

—

Total services

155

Distinct HCPCS

Medicare payment

$8K

Peer benchmark

Total Medicare services vs. 7,864 Internal Medicine providers in NY — below median (cohort median 552).

PRESCRIBING · PART D · 2024

Total Rx claims

5,948

Beneficiaries

—

Total drug cost

$525K

Distinct drugs

Brand share

17.4%

Top prescribed drugs

Atorvastatin Calcium478 claims

Metoprolol Succinate306 claims

Amlodipine Besylate285 claims

Lisinopril263 claims

Levothyroxine Sodium251 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Ripple Marfatia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
WYOMING COUNTY	78	1,040
Glauco Maresca Diagnostic Radiology · Potsdam, NY	37	185
Brian Ewy Diagnostic Radiology · Kennebunk, ME	25	107
Terence Schumpert Diagnostic Radiology · Massena, NY	17	113
Tarun Ohri Internal Medicine · Warsaw, NY	17	125
James Lanigan Internal Medicine · Warsaw, NY	11	50
Alexandra Wesley Diagnostic Radiology · Williamsville, NY	11	39

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history